A multicenter,openlabel,randomized controlled traial for the head-to-head comparison of minodronic acid hydroate and raloxifene hydrocloride
Phase 4
Completed
- Conditions
- Osteoporosis
- Registration Number
- JPRN-UMIN000005433
- Lead Sponsor
- Research committee of A-TOP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 3500
Inclusion Criteria
Not provided
Exclusion Criteria
Using therapeutic drug contraindications,Secondary osteoporousis and Disease with low bone mass, Advanced variant T4-L4, Heart disease,liver disease,kidney failure or other serious complications Problems with the reliability of interview data Treatment of malignant tumors that may affect bone metabolism
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Osteoporotic fractures,Vertebral fractures,Major osteoporotic fractures
- Secondary Outcome Measures
Name Time Method Bone density,HSA,height,Bone-related markers,lipid,Oral interview surveys,the number of falls,falls score,care level,morter function,QOL,Safty